Oxford University Press, Open Forum Infectious Diseases, 4(2), 2015
DOI: 10.1093/ofid/ofv144
Full text: Download
Abstract Combination antiretroviral therapy during primary human immunodeficiency virus-1 infection may enable long-term drug-free virological control in rare individuals. We describe a female who maintained aviremia and a normal CD4+/CD8+ T cell ratio for 10 years after stopping therapy, despite a persistent viral reservoir. Cellular immune responses may have contributed to this outcome.